eCancerMedicalScience

Scope & Guideline

Bridging research and practice in cancer care.

Introduction

Delve into the academic richness of eCancerMedicalScience with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageItalian
ISSN1754-6605
PublishereCancer Global Foundation
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Converge2007, from 2009 to 2024
AbbreviationECANCERMEDICALSCIENC / eCancerMedicalScience
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address13 King Square Avenue, Bristol BS2 8HU, UNITED KINGDOM

Aims and Scopes

The journal 'eCancerMedicalScience' aims to advance knowledge in the field of oncology through a diverse range of research articles that focus on cancer epidemiology, treatment strategies, and healthcare delivery, particularly in low- and middle-income countries. The journal emphasizes the importance of addressing the unique challenges faced in these regions while promoting innovative solutions and collaborations across disciplines.
  1. Cancer Epidemiology and Public Health:
    The journal covers studies that analyze cancer incidence, prevalence, and mortality rates, particularly in underrepresented populations, thereby contributing to a more comprehensive understanding of cancer's impact globally.
  2. Innovative Treatment Modalities:
    Research articles focus on novel therapies, including immunotherapy, targeted treatments, and combination therapies, highlighting their effectiveness in diverse patient populations and addressing disparities in access to care.
  3. Healthcare Systems and Policy:
    The journal explores the intersection of cancer care and health policy, examining how healthcare systems can be optimized to improve access, quality, and equity in cancer treatment, especially in resource-limited settings.
  4. Patient-Centered Care and Survivorship:
    The scope includes studies on quality of life, psychosocial aspects of cancer care, and survivorship issues, emphasizing the importance of holistic approaches to cancer treatment.
  5. Educational and Training Initiatives:
    The journal promotes articles that assess and enhance oncology education and training for healthcare professionals, particularly in low-resource environments, to improve cancer management and outcomes.
The journal has identified several emerging themes in recent publications that reflect the evolving landscape of cancer research and treatment, particularly in response to global health challenges and advancements in technology.
  1. Telemedicine and Digital Health Solutions:
    The rise of telemedicine, especially during the COVID-19 pandemic, has led to increased research on its implementation in oncology, highlighting its potential to improve access to care and patient outcomes.
  2. Health Disparities and Access to Care:
    There is a growing focus on understanding and addressing disparities in cancer care, particularly in low- and middle-income countries, emphasizing the need for equitable healthcare solutions.
  3. Immunotherapy and Personalized Medicine:
    An increasing number of studies are dedicated to exploring immunotherapy and personalized treatment plans, reflecting a shift towards more effective and individualized cancer treatments.
  4. Survivorship and Quality of Life Research:
    Research on survivorship issues, including long-term effects of cancer treatment and quality of life assessments, is gaining traction, emphasizing the importance of holistic care for cancer survivors.
  5. Interdisciplinary Approaches in Cancer Care:
    Emerging themes include the integration of different specialties in cancer treatment, such as combining surgical, medical, and supportive care, to enhance patient outcomes and streamline treatment pathways.

Declining or Waning

While 'eCancerMedicalScience' has consistently focused on various aspects of oncology, certain themes have shown a decline in prominence over recent years. This may reflect shifting priorities in cancer research or changes in the global healthcare landscape.
  1. Traditional Chemotherapy Approaches:
    There has been a noticeable decrease in publications focusing solely on conventional chemotherapy regimens, as research increasingly shifts towards personalized medicine and targeted therapies that offer more effective treatment options.
  2. General Cancer Awareness Campaigns:
    While still relevant, the frequency of articles solely dedicated to general cancer awareness initiatives has decreased, possibly due to a growing emphasis on specific interventions and evidence-based strategies tailored to particular populations.
  3. Palliative Care Focused Studies:
    Although palliative care remains crucial, there has been a waning interest in studies that do not integrate palliative approaches with oncological treatments, suggesting a trend towards more comprehensive care models.
  4. Single-Institution Studies:
    Research focusing exclusively on single-institution experiences is becoming less common, as collaborative and multi-centre studies gain traction, reflecting a desire for broader applicability and generalizability of findings.
  5. Basic Science and Laboratory Research:
    There appears to be a decline in studies rooted in basic science related to oncology, as clinical applications and translational research take precedence in addressing urgent clinical needs.

Similar Journals

Cancer Research Communications

Connecting researchers for a cancer-free future.
Publisher: AMER ASSOC CANCER RESEARCHISSN: Frequency: 1 issue/year

Cancer Research Communications is an esteemed journal published by the American Association for Cancer Research, a leading organization in the field of oncology. This journal aims to advance knowledge in cancer research through the dissemination of high-quality, peer-reviewed articles that cover a wide range of topics related to cancer biology, treatment modalities, and prevention strategies. As an open-access journal, Cancer Research Communications ensures that vital research findings are accessible to a global audience, promoting collaboration and innovation within the scientific community. The journal serves as a crucial platform for researchers, professionals, and students to share their insights and foster the exchange of effective cancer therapies and methodologies. With a commitment to excellence, it plays a significant role in shaping the future of cancer research and therapeutic development.

Translational Oncology

Pioneering the Next Generation of Cancer Treatments
Publisher: ELSEVIER SCIENCE INCISSN: 1936-5233Frequency: 6 issues/year

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

Oncology Letters

Empowering Oncology with Groundbreaking Discoveries
Publisher: SPANDIDOS PUBL LTDISSN: 1792-1074Frequency: 12 issues/year

Oncology Letters is a prominent academic journal dedicated to disseminating high-quality research in the fields of oncology and cancer research. Published by SPANDIDOS PUBL LTD and based in Greece, this journal has established a significant presence since its inception in 2010 and continues to contribute to the scientific community with a focus on both clinical and experimental oncology. Notably, it holds a respectable Q3 ranking in the categories of Cancer Research and Oncology as of 2023, highlighting its relevance and contribution to these critical fields. With a Scopus rank of #139/404 in Medicine – Oncology and #117/230 in Biochemistry, Genetics, and Molecular Biology – Cancer Research, Oncology Letters serves as a valuable platform for researchers, professionals, and students alike to explore emerging findings and innovative treatment approaches. Though it operates within a traditional subscription model, this journal prides itself on fostering accessible and impactful discourse in oncology, making it an essential resource for those committed to advancing cancer research and improving patient care.

ONCOLOGY RESEARCH

Pioneering Insights in Oncology and Medicine
Publisher: TECH SCIENCE PRESSISSN: 0965-0407Frequency: 6 issues/year

ONCOLOGY RESEARCH, published by TECH SCIENCE PRESS, is a vital academic journal dedicated to the rapidly evolving field of oncology. With its ISSN 0965-0407 and E-ISSN 1555-3906, the journal serves as a key resource for researchers, clinicians, and academicians committed to advancing cancer research and treatment strategies. Operating without an Open Access model, ONCOLOGY RESEARCH provides high-quality, peer-reviewed articles that cover diverse topics within cancer research, medicine, and oncology, with its 2023 Scopus ranking placing it in the Q3 quartile. The journal's commitment to facilitating rigorous scientific discourse is evident in its historical breadth, with a publishing history dating back to 1992. ONCOLOGY RESEARCH is not only significant for the academic community but also plays a critical role in fostering new insights and approaches in the fight against cancer, making it a must-read for those involved in this critical area of study.

CANCER TREATMENT REVIEWS

Fostering collaboration in the fight against cancer.
Publisher: ELSEVIER SCI LTDISSN: 0305-7372Frequency: 10 issues/year

Cancer Treatment Reviews, published by Elsevier Science Ltd, is a leading international journal dedicated to the exploration and advancement of therapeutic strategies in oncology. With an impressive impact factor that reflects its status in the field, this journal is classified within Q1 quartile rankings in Medicine (Miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging, as of 2023. The journal has a rich lineage, having been established in 1974 and consistently evolving to encompass the latest breakthroughs and methodologies in cancer treatment. A vital resource for researchers, clinicians, and students alike, it aims to promote understanding and application of effective interventions, thereby contributing to improvements in patient outcomes. By prioritizing high-quality reviews, Cancer Treatment Reviews plays an essential role in bridging the gap between current research and clinical practice, making it an indispensable asset in the continuous fight against cancer.

Cancers

Connecting researchers for a cancer-free future.
Publisher: MDPIISSN: Frequency: 24 issues/year

Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

South Asian Journal of Cancer

Illuminating breakthroughs in oncology and prevention.
Publisher: GEORG THIEME VERLAG KGISSN: 2278-330XFrequency: 4 issues/year

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

Cancer Management and Research

Elevating patient outcomes through collaborative research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1322Frequency: 1 issue/year

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Oncology in Clinical Practice

Transforming Patient Care with Cutting-Edge Research
Publisher: VIA MEDICAISSN: 2450-1654Frequency: 6 issues/year

Oncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.

ACTA ONCOLOGICA

Elevating standards in oncology research and practice.
Publisher: Medical Journal Sweden ABISSN: 0284-186XFrequency: 12 issues/year

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.